Targeted Knockdown of the RNA-binding Protein CRD-BP Promotes Cell Proliferation via an Insulin-like Growth Factor II-dependent Pathway in Human K562 Leukemia Cells
Open Access
- 1 November 2004
- journal article
- Published by Elsevier BV
- Vol. 279 (47), 48716-48724
- https://doi.org/10.1074/jbc.m405853200
Abstract
The c-myc mRNA coding region determinant-binding protein (CRD-BP) was first identified as a masking protein that stabilizes c-myc mRNA in a cell-free mRNA degradation system. Thus, CRD-BP is thought to promote cell proliferation by maintaining c-Myc at critical levels. CRD-BP also appears to be an oncofetal protein, based upon its expression during mammalian development and in some tumors. By using K562 leukemia cells as a model, we show that CRD-BP gene silencing by RNA interference significantly promoted proliferation, indicating an inhibitory effect of CRD-BP on proliferation. Unexpectedly, CRD-BP knockdown had no discernible effect on c-myc mRNA levels. CRD-BP is also known as insulin-like growth factor II (IGF-II) mRNA-binding protein-1. It has been reported to repress translation of a luciferase reporter mRNA containing an IGF-II 5′-untranslated region known as leader 3 but not one containing IGF-II leader 4. CRD-BP knockdown markedly increased IGF-II mRNA and protein levels but did not alter translation of luciferase reporter mRNAs containing 5′-untranslated regions consisting of either IGF-II leader 3 or leader 4. Addition of antibody against IGF-II to cell cultures inhibited the proliferative effect of CRD-BP knockdown, suggesting that regulation of IGF-II gene expression, rather than c-myc mRNA levels, mediates the proliferative effect of CRD-BP knockdown. Thus, we have identified a dominant function for CRD-BP in cell proliferation of human K562 cells, involving a possible IGF-II-dependent mechanism that appears independent of its ability to serve as a c-myc mRNA masking protein.Keywords
This publication has 59 references indexed in Scilit:
- Systematic functional analysis of the Caenorhabditis elegans genome using RNAiNature, 2003
- Regulation of c-myc mRNA Decay by Translational Pausing in a Coding Region Instability DeterminantMolecular and Cellular Biology, 2002
- C‐MYC and IGF‐II mRNA‐binding protein (CRD‐BP/IMP‐1) in benign and malignant mesenchymal tumorsInternational Journal of Cancer, 2001
- Overexpression of an mRNA-binding protein in human colorectal cancerOncogene, 2001
- Regulation of c-myc mRNA Decay in Vitro by a Phorbol Ester-inducible, Ribosome-associated Component in Differentiating MegakaryoblastsPublished by Elsevier BV ,2000
- The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic GrowthEndocrine Reviews, 2000
- myc FUNCTION AND REGULATIONAnnual Review of Biochemistry, 1992
- Receptor binding and mitogenic effects of insulin and insulinlike growth factors I and II for human myeloid leukemic cellsJournal of Cellular Physiology, 1987
- IGF-2 stimulated growth mediated by the somatomedin type 2 receptorBiochemical and Biophysical Research Communications, 1987
- Insulin-Like Growth Factors/Somatomedins: Structure, Secretion, Biological Actions and Physiological RoleHormone Research, 1986